Bullboard - Stock Discussion Forum Anavex Life Sciences Corp AVXL

Healthcare Biotechnology

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

Add To Watchlist

NDAQ:AVXL - Post Discussion

Anavex Life Sciences Corp > End of Month - November 2019

View:

Post by R_J_ on Dec 01, 2019 7:58am

End of Month - November 2019

End of the Month (EOM) report for November 2019.
-
AVXL closed on 11/29/2019 at US$2.40
AVXL closed on 10/31/2019 at US$2.72
-
This is a 11.8%, a 32-cent, loss for November.
-
S&P 500 Index, @ 3140.9 gained 3.4% in November. [7.3% above its MA(200) @ 2,927.1]
-
Two Hundred Day Moving Average [MA(200)] stuff.
AVXL's MA(200) ended November at $2.90
AVXL is now 17.2% below its MA(200).
-
News Releases on the AVXL Website in November
-
Use this link to see and read the all of November’s News Releases.
-
https://www.anavex.com/2019/11/
-
RJ

131